OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles
Xiang Li, Xin Wang, Qiangqiang Jiao, et al.
Acta Biomaterialia (2023) Vol. 168, pp. 497-514
Open Access | Times Cited: 12
Xiang Li, Xin Wang, Qiangqiang Jiao, et al.
Acta Biomaterialia (2023) Vol. 168, pp. 497-514
Open Access | Times Cited: 12
Showing 12 citing articles:
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 23
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 23
Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements
Zheng Chen, Maoyu Liu, Ningyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3244-3273
Closed Access | Times Cited: 9
Zheng Chen, Maoyu Liu, Ningyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3244-3273
Closed Access | Times Cited: 9
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
Feng Gao, Xuefei Feng, Xinyu Li
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Feng Gao, Xuefei Feng, Xinyu Li
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Deletion of GPR81 activates CREB/Smad7 pathway and alleviates liver fibrosis in mice
Ying Zhi, Kerui Fan, Shuang Liu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Ying Zhi, Kerui Fan, Shuang Liu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Ribosome biogenesis: A central player in liver diseases
Wei Luo, Jing Zhou, Yongmin Yan, et al.
Genes & Diseases (2025), pp. 101512-101512
Open Access
Wei Luo, Jing Zhou, Yongmin Yan, et al.
Genes & Diseases (2025), pp. 101512-101512
Open Access
Inhibition of HSC proliferation and hepatic fibrogenesis with Erythrocyte membrane coated Doxorubicin/Black phosphorus nanosheets
Xiang Li, Xianjing Xiang, Qiangqiang Jiao, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125403-125403
Closed Access
Xiang Li, Xianjing Xiang, Qiangqiang Jiao, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125403-125403
Closed Access
Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCs
Xianjing Xiang, Yaru Shao, Xiang Li, et al.
Molecular Pharmaceutics (2025)
Closed Access
Xianjing Xiang, Yaru Shao, Xiang Li, et al.
Molecular Pharmaceutics (2025)
Closed Access
Amphiphilic Lipid Conjugate-mediated surface engineering of Placenta-Derived mesenchymal stem cells for alleviating liver damage and fibrosis
Sungjun Kim, Dae Hyun Lee, Hee Won Park, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158313-158313
Closed Access | Times Cited: 2
Sungjun Kim, Dae Hyun Lee, Hee Won Park, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158313-158313
Closed Access | Times Cited: 2
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis
Yue Yuan, Jiaxuan Li, Min Chen, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 318-336
Closed Access
Yue Yuan, Jiaxuan Li, Min Chen, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 318-336
Closed Access
Targeting hyperactive mitochondria in activated HSCs and inhibition of liver fibrogenesis in mice using sorafenib complex micelles
Xiang Li, Yuting Qin, Lei Li, et al.
International Journal of Pharmaceutics (2024), pp. 125058-125058
Closed Access
Xiang Li, Yuting Qin, Lei Li, et al.
International Journal of Pharmaceutics (2024), pp. 125058-125058
Closed Access
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Xun� Li, Yongqiang Zhou, Jiexi Yan, et al.
Research Square (Research Square) (2023)
Open Access
Xun� Li, Yongqiang Zhou, Jiexi Yan, et al.
Research Square (Research Square) (2023)
Open Access
